[{"uuid": "810923ef-6ea9-3d7a-97ab-70bdd293317d", "title": "ADC Therapeutics Makes Grants to New Employees Under Inducement Plan", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/adc-therapeutics-makes-grants-employees-210500188.html", "providerPublishTime": 1738616700, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Et0V8U3X6l.Laaek.1Xhrg--~B/aD0yNTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b45d5be0d129d2f2b168ba1839a068c7", "width": 400, "height": 250, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/1vTJuOJDAByrvQhxuKTC_g--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/b45d5be0d129d2f2b168ba1839a068c7", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ADCT"]}, {"uuid": "0d4f7bb9-b7fa-3afa-bdb9-20e245bca3bf", "title": "Pyxis Oncology Initiates New PYX-201 Combination Trial and Initiates Cohort Expansions of Ongoing Monotherapy Trial", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/pyxis-oncology-initiates-pyx-201-123000501.html", "providerPublishTime": 1738672200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/0cotbcbwgxGKBggahIXGgQ--~B/aD0xMDU7dz0yMDM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/f29ebfcc4cb165c9ba2efd1387b8fa81", "width": 203, "height": 105, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/9g9wlsUb_KaAykCDWWnjNw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/f29ebfcc4cb165c9ba2efd1387b8fa81", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["PYXS"]}, {"uuid": "0d58cc1f-f021-39ba-be3f-e0b8b449f8fb", "title": "Abbott's 'Above the Bias' Film Reveals Misconceptions Can Impact Diabetes Care", "publisher": "CNW Group", "link": "https://finance.yahoo.com/news/abbotts-above-bias-film-reveals-162700172.html", "providerPublishTime": 1738686420, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/oAJuCeNX9vFHzn4wFzUWtA--~B/aD0yMjU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cnwgroup.com/cb202a1be6715aa56247a5b3542a687f", "width": 400, "height": 225, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/fe3HCozffVi6x.4aRMR55A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/cnwgroup.com/cb202a1be6715aa56247a5b3542a687f", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ABT"]}, {"uuid": "8b4e54bd-513f-3682-810b-250bc6eaf381", "title": "Should Investors Hold Chemed Stock in Their Portfolio Now?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/investors-hold-chemed-stock-portfolio-140500398.html", "providerPublishTime": 1738677900, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/GmVc8.ZtfGjPFG_U83F8fA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/H7LTwaRmshxenlNcNQKw1w--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CHE"]}, {"uuid": "dc619c53-95a2-3303-a0d9-5c815c7ce7b8", "title": "The State of the Biopharmaceutical Industry 2025: Impact of Emerging Technologies, Industry and Regulatory Trends, and Macroeconomic Factors for the Next 12 Months", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/state-biopharmaceutical-industry-2025-impact-141000723.html", "providerPublishTime": 1738678200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/HP.E8HUfnyGeLtMAKwLgAQ--~B/aD01ODt3PTQ4MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc", "width": 480, "height": 58, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/KPtVInxraKsLNBMRw1U5aw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "1b4eee66-b153-3649-8e34-1c412e82c305", "title": "OS Therapies Provides Corporate Update", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/os-therapies-provides-corporate-123300607.html", "providerPublishTime": 1738672380, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Dw4Ef0oH6yFPnnPx7u0nyg--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/372b62352c9bb9815b919984a8b3cfe1", "width": 1024, "height": 512, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/vki_goBQ15VbRIVIh17Tfw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/372b62352c9bb9815b919984a8b3cfe1", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["OSTX"]}, {"uuid": "7cfc50c7-0606-30f7-81a0-8094f86212fc", "title": "Vans Debuts Premium Old Skool Music Collection", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/vans-debuts-premium-old-skool-120000257.html", "providerPublishTime": 1738670400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/wjk8Nbl3kywoZ_VZ9studQ--~B/aD0yNjc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/afdf64bc2e9b3a08cf677e217bdab12c", "width": 400, "height": 267, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/y5XYyeCTUsOQezUNvNMoJQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/afdf64bc2e9b3a08cf677e217bdab12c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["VFC"]}, {"uuid": "d1e2e14a-cba1-3b5e-89a6-7047008cfc62", "title": "HURA: Initiating an Immune Response", "publisher": "Zacks Small Cap Research", "link": "https://finance.yahoo.com/news/hura-initiating-immune-response-091600422.html", "providerPublishTime": 1738660560, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/QwGVz4vFChe5ZSrYrybCbA--~B/aD04Mjg7dz0xNzg0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/scr.zacks.com/4b66c739747880b0055eb04ec918f0bf", "width": 1784, "height": 828, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/NPa9WbAhg8dtl13by2.XSw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/scr.zacks.com/4b66c739747880b0055eb04ec918f0bf", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["HURA"]}, {"uuid": "79a2b178-09f1-3baa-b402-27d19d644c1a", "title": "Survey Reveals: 88% of Western Europeans Would Like Better Information on Breast Cancer, Misconceptions and Lack of Awareness of the Disease Still Prevail", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/survey-reveals-88-western-europeans-070000054.html", "providerPublishTime": 1738652400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/i687RMj4iL_hrvriYy1dfA--~B/aD00NzQ7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/192ed373f407e03e495ab53fbe1e0349", "width": 480, "height": 474, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/ycUobO1WUyTkfJtplTd4Gw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/192ed373f407e03e495ab53fbe1e0349", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["DSKYF", "DSNKY"]}, {"uuid": "4ee6a371-479a-3090-a753-a6d6bccf289f", "title": "Akari Therapeutics Joins Webull Corporate Connect Service Platform", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/akari-therapeutics-joins-webull-corporate-130000114.html", "providerPublishTime": 1738587600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/RafZoEtOBHqt_qicXb0WjQ--~B/aD01MjA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/3a8364c339afb7bc94d41986349f759b", "width": 600, "height": 520, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/FHYWUugV5oyLOlNbv78.vw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/3a8364c339afb7bc94d41986349f759b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AKTX"]}, {"uuid": "48ea2d9e-00bc-353d-bc5f-225c6171f157", "title": "F5, Inc. (FFIV): Wall Street is Talking About This Under-The-Radar AI Stock", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/f5-inc-ffiv-wall-street-204429147.html", "providerPublishTime": 1738615469, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/83lEcYqPoOPhmzin6nEF8Q--~B/aD01MTU7dz05MzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/e82bbc1fd07e08efde71771bf5112e97", "width": 930, "height": 515, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/tzLn_UNm2T.vvhN7SD40ww--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/e82bbc1fd07e08efde71771bf5112e97", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["FFIV"]}, {"uuid": "2cd75e71-6fa9-37c5-aa94-225a48ab30a4", "title": "Datar Cancer Genetics Unveils Next Generation Multi-Analyte, AI-Powered Decision Support Platform for Personalized Treatment of Difficult-to-Treat Cancers.", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/datar-cancer-genetics-unveils-next-164300058.html", "providerPublishTime": 1738600980, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ycy2n4ZYa.1yAapq6PvxmA--~B/aD0yNTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/c5a42e0980f988c9f30409dc38ddb5fd", "width": 400, "height": 250, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/lDLDrleg9J3GMAUbsZioog--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/c5a42e0980f988c9f30409dc38ddb5fd", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "fb3a6574-b3de-3870-9adb-47aa3b43c6f1", "title": "BioNTech Completes Acquisition of Biotheus", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/biontech-completes-acquisition-biotheus-114500580.html", "providerPublishTime": 1738583100, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/RTbgr5.LOqZ4O1Eb330Lyg--~B/aD0zMDE7dz0yNzI5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/823794cd8a992e0c9057cc4e398068ea", "width": 2729, "height": 301, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/cVTn8jI33mLXHTj7GGphog--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/823794cd8a992e0c9057cc4e398068ea", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BNTX"]}, {"uuid": "97715770-49db-3797-9463-a36fd00f83ea", "title": "Pfizer drug acquired in $11B buyout confirms benefit in colon cancer", "publisher": "BioPharma Dive", "link": "https://finance.yahoo.com/m/97715770-49db-3797-9463-a36fd00f83ea/pfizer-drug-acquired-in-%2411b.html", "providerPublishTime": 1738583100, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/wm4Y9cn3eehzMUIa6kXtRg--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/biopharma_dive_768/aa7c0bd6fd4020b762d40ce352516358", "width": 1600, "height": 900, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/uRjdH.h2fslFBWMyk45swQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/biopharma_dive_768/aa7c0bd6fd4020b762d40ce352516358", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["PFE"]}, {"uuid": "5a9c8a41-562e-3284-a647-fc057d18868d", "title": "ADC Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/adc-therapeutics-participate-guggenheim-smid-121500438.html", "providerPublishTime": 1738239300, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Et0V8U3X6l.Laaek.1Xhrg--~B/aD0yNTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b45d5be0d129d2f2b168ba1839a068c7", "width": 400, "height": 250, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/1vTJuOJDAByrvQhxuKTC_g--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/b45d5be0d129d2f2b168ba1839a068c7", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ADCT"]}, {"uuid": "a265008a-bbb1-3aac-9a8d-295dfbe25001", "title": "Defence Closes Second Tranche of Fully Subscribed Financing Totaling $4.2 Million", "publisher": "Newsfile", "link": "https://finance.yahoo.com/news/defence-closes-second-tranche-fully-230000362.html", "providerPublishTime": 1738364400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/D.Lm6gtzb5OY2qaxTDButA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/215c7ef61942734ce9b232b9b4fe527d", "width": 400, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/BhI8JWwaA2LR507SwJThkg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/newsfile_64/215c7ef61942734ce9b232b9b4fe527d", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["DTCFF"]}, {"uuid": "72d22a89-35b0-383e-8a08-223a114fa65b", "title": "Q4 2024 AbbVie Inc Earnings Call", "publisher": "Thomson Reuters StreetEvents", "link": "https://finance.yahoo.com/news/q4-2024-abbvie-inc-earnings-062602319.html", "providerPublishTime": 1738391162, "type": "STORY", "relatedTickers": ["ABBV"]}, {"uuid": "d8e08644-2d00-3d71-8401-814216fc4919", "title": "Q4 2024 Hartford Financial Services Group Inc Earnings Call", "publisher": "Thomson Reuters StreetEvents", "link": "https://finance.yahoo.com/news/q4-2024-hartford-financial-services-070633863.html", "providerPublishTime": 1738393593, "type": "STORY", "relatedTickers": ["HIG"]}, {"uuid": "652c0ab5-5ce5-3eee-92eb-a955fc8a2469", "title": "Antibodies Market Expected To Reach USD 865.62 Billion by 2032, Growing at CAGR 13.93% To Forecast 2024-2032", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/antibodies-market-expected-reach-usd-113900141.html", "providerPublishTime": 1738323540, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Vej2w0O7P7T9_zSvIycQXw--~B/aD0zNDU7dz02MTA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/469f7321b6e03940c8dd7494106b4721", "width": 610, "height": 345, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/iOyFsUpUAn5qf7VRvI89wA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/469f7321b6e03940c8dd7494106b4721", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "aadb46fb-5b75-320b-a9d7-57d108ef6851", "title": "Immunome Announces Closing of Upsized Public Offering and Full Exercise of Underwriters\u2019 Option to Purchase Additional Shares", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/immunome-announces-closing-upsized-public-210100215.html", "providerPublishTime": 1738357260, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/91PlATXbihFgPvJX_CKF_g--~B/aD0zMzQ7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/3c1188458a649ec416588ec5763c42bc", "width": 480, "height": 334, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/KYASxGYl5wXfNUGBrhV9Rw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/3c1188458a649ec416588ec5763c42bc", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["IMNM"]}]